Author

Christina Nuttall

Observed names: C. Nuttall, Christina L. Nuttall, Nuttall, C., Nuttall, Christina

Institutions: The Christie Hospital, The Christie NHS Foundation Trust

Observed institutions: National Health Service, University of Manchester, The Christie Hospital, The Christie NHS Foundation Trust

OpenAlex ID: A5050591807

Sorafenib as first-line therapy in patients with advanced Child-Pugh B hepatocellular carcinoma—a meta-analysis

2018 · Mairéad Geraldine McNamara, Astrid E. Slagter, et al. · European Journal of Cancer · 99

Carboplatin in Combination with Oral or Intravenous Etoposide for Extra-Pulmonary, Poorly-Differentiated Neuroendocrine Carcinomas

2019 · Melissa Frizziero, Francesca Spada, et al. · Neuroendocrinology · 50

Somatostatin analogue-induced pancreatic exocrine insufficiency in patients with neuroendocrine tumors: results of a prospective observational study

2018 · Angela Lamarca, Lynne McCallum, et al. · Expert Review of Gastroenterology & Hepatology · 50

The Impact of 68Gallium DOTA PET/CT in Managing Patients With Sporadic and Familial Pancreatic Neuroendocrine Tumours

2021 · Daniel J. Cuthbertson, Jorge Barriuso, et al. · Frontiers in Endocrinology · 29

PDF

Relevant Study: Patient and Clinician Perspectives on Clinically-Meaningful Outcomes in Advanced Pancreatic Cancer

2023 · Rille Pihlak, Melissa Frizziero, et al. · Cancers · 9

PDF

Temozolomide-capecitabine (TemCap) chemotherapy for neuroendocrine neoplasms (NENs): Time to maximum response and optimal treatment duration

2017 · A. Lamarca, J. Barriuso, et al. · Annals of Oncology · 6

Identification of patients with pancreatic adenocarcinoma due to inheritable mutation: Challenges of daily clinical practice

2019 · Alexander JP Fulton, Angela Lamarca, et al. · World Journal of Gastrointestinal Oncology · 5

Pathological & radiological variables in the diagnosis of bronchopulmonary carcinoids (BPCs) with a focus on Antigen Kiel 67 (Ki-67) proliferation index

2025 · Gaurav Ahuja, Aparna Iyer, et al. · Lung Cancer · 4

Prognosis Discussion and Referral to Community Palliative Care Services in Patients with Advanced Pancreatic Cancer Treated in a Tertiary Cancer Centre

2023 · Sarah Clelland, Christina L. Nuttall, et al. · Healthcare · 2

PDF

Carboplatin (CB) combined with oral or intravenous (IV) etoposide (ET) for advanced extra-pulmonary (EP) poorly differentiated (PD) neuroendocrine carcinoma (NEC): Real-world findings from two European neuroendocrine tumour society centres of excellence

2018 · M. Frizziero, F. Spada, et al. · Annals of Oncology · 2

Pancreatic exocrine insufficiency (PEI) in patients (pts) with well-differentiated neuroendocrine tumours (wd-NETs) treated with somatostatin analogues (SSAs): Incidence and impact on quality of life

2017 · A. Lamarca, L. McCallum, et al. · Annals of Oncology · 2

P-274 RELEVANT study: Patient and physician perspectives on clinically-meaningful outcomes in advanced pancreatic ductal adenocarcinoma

2020 · R. Pihlak, M. Frizziero, et al. · Annals of Oncology · 1

PDF

Carboplatin-etoposide chemotherapy (CB-ET) for patients diagnosed with advanced extra-pulmonary (EP) poorly differentiated (PD) neuroendocrine carcinoma (NEC): findings from a European Neuroendocrine Tumor Society Centre of Excellence.

2018 · Melissa Frizziero, Ángela Lamarca, et al. · Research Explorer (The University of Manchester) · 1

Carboplatin-etoposide chemotherapy for patients with advanced extra-pulmonary (EP) poorly differentiated (PD) neuroendocrine carcinoma (NEC); outcomes from a European Neuroendocrine Tumour Society Centre of Excellence

2017 · Melissa Frizziero, Angela Lamarca, et al. · Endocrine Abstracts · 1

Efficacy of somatostatin analogues versus other systemic therapies as first-line palliative treatment for patients with advanced, grade 2, well-differentiated neuroendocrine tumours of extra-pulmonary origin with a Ki-67 index between 10% and 20%

2025 · Eleni Vrana, Klaire Exarchou, et al. · Endocrine Abstracts

Real-world outcomes for PRRT in patients with well differentiated gastroenteropancreatic neuroendocrine tumours

2025 · Christina Nuttall, Manyi Eyong, et al. · Endocrine Abstracts

P-123 Prognosis discussion and referral to community palliative care services (CPCS) in patients with advanced pancreas cancer (APC)

2022 · Sarah Clelland, Christina Nuttall, et al. · BMJ Supportive & Palliative Care

RELEVANT study: Patient (Pt) and physician (PI) perspectives on meaningful outcomes in advanced pancreatic ductal adenocarcinoma (PDAC).

2020 · Rille Pihlak, Melissa Frizziero, et al. · Journal of Clinical Oncology

Hepatic arterial embolisation for patients diagnosed with neuroendocrine neoplasms: experience from a European Neuroendocrine Tumour Society centre of excellence

2019 · Christina Nuttall, Angela Lamarca, et al. · Endocrine Abstracts

Supplementary Material for: Carboplatin in Combination with Oral or Intravenous Etoposide for Extra-Pulmonary, Poorly-Differentiated Neuroendocrine Carcinomas

2019 · Frizziero, M., Spada, F., et al. · Figshare

The impact of 68Ga-based PET-CT scanning on the management of patients with familial pancreatic neuroendocrine tumours (panNETs)

2018 · Daniel Cuthbertson, Jorge Barriuso, et al. · Endocrine Abstracts

Pancreatic exocrine insufficiency (PEI) secondary to chronic use of long-acting (LA) somatostatin analogues (SSA) in pts with neuroendocrine tumors (NETs): Pooled analysis (USA and UK).

2018 · Wasif M. Saif, Angela Lamarca, et al. · Journal of Clinical Oncology

Works count: 23

Citation count: 261

H-index: 6

I10-index: 4